Form 4 Tracker
Dawn Svoronos

Director · 2 filings · Latest: Sep 1, 2026

Xenon Pharmaceuticals Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
XENE
Dawn SvoronosDirectorSep 1, 2026
Option Exercise
$8.155,144$41.9K31,373
XENE
Dawn SvoronosDirectorJun 1, 2026
Option Exercise
—2,645—27,645